These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15204165)

  • 1. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
    Vereecken P; Monsieur E; Petein M; Heenen M
    J Dermatolog Treat; 2004 Apr; 15(2):120-1. PubMed ID: 15204165
    [No Abstract]   [Full Text] [Related]  

  • 2. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
    Marks R; Owens M; Walters SA;
    Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
    Micali G; De Pasquale R; Caltabiano R; Impallomeni R; Lacarrubba F
    J Dermatolog Treat; 2002 Sep; 13(3):123-7. PubMed ID: 12227875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
    Kocabaş E; Ermertcan AT; Bilaç C; Bilaç DB; Temiz P
    Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream.
    Ferreres JR; Macaya A; Jucglà A; Muniesa C; Prats C; Peyrí J
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):877-8. PubMed ID: 16898919
    [No Abstract]   [Full Text] [Related]  

  • 7. Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up.
    Vidal D; Matías-Guiu X; Alomar A
    Arch Dermatol; 2007 Feb; 143(2):266-8. PubMed ID: 17310012
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical treatment of basal cell carcinoma with the immune response modifier imiquimod.
    Papakostas D; Stockfleth E
    Future Oncol; 2015 Nov; 11(22):2985-90. PubMed ID: 26450707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.
    Harting M; Vujevich J; Goldberg LH
    Dermatol Surg; 2007 Dec; 33(12):1516-9. PubMed ID: 18076623
    [No Abstract]   [Full Text] [Related]  

  • 10. Localized pemphigus foliaceus induced by topical imiquimod treatment.
    Lin R; Ladd DJ; Powell DJ; Way BV
    Arch Dermatol; 2004 Jul; 140(7):889-90. PubMed ID: 15262711
    [No Abstract]   [Full Text] [Related]  

  • 11. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM
    Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of basal cell cancer in an HIV positive patient with topical imiquimod.
    Scott DR
    J Drugs Dermatol; 2004; 3(6):602. PubMed ID: 15624742
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.
    Santiago Sánchez-Mateos D; Goiriz Valdés R; Daudén Tello E
    Clin Exp Dermatol; 2010 Mar; 35(2):199-200. PubMed ID: 19486047
    [No Abstract]   [Full Text] [Related]  

  • 14. Imiquimod - Its role in the treatment of cutaneous malignancies.
    Bubna AK
    Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has imiquimod 5% cream a role in the management of recurrent basal cell carcinoma?
    RUIZ-VILLAVERDE R; SANCHEZ-CANO D; BURKHARDT-PEREZ P; SINTES RN
    Eur J Dermatol; 2009; 19(5):481-3. PubMed ID: 19527989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
    Akkilic-Materna M; Massone C; Komericki P
    Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Rub on' treatment for basal-cell carcinoma.
    Kerr C
    Lancet Oncol; 2002 Apr; 3(4):201. PubMed ID: 12067676
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
    Turan A; Saricaoglu H; Baskan EB; Toker SC; Tunali S
    Int J Dermatol; 2009 Feb; 48(2):214-5. PubMed ID: 19200213
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream.
    Yang JQ; Chen XY; Engle MY; Wang JY
    Dermatol Ther; 2015; 28(4):243-7. PubMed ID: 25754701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.